Learn more

ABBVIE IRELAND UNLIMITED CO

Overview
  • Total Patents
    153
  • GoodIP Patent Rank
    26,351
  • Filing trend
    ⇩ 71.0%
About

ABBVIE IRELAND UNLIMITED CO has a total of 153 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2006. It filed its patents most often in Australia, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are NAT INST OF BIOLOGICAL SCIENCES BEIJING, MOLECULAR INSIGHT PHARM INC and YAMANOUCHI PHARMACEUTICAL CO LTD.

Patent filings per year

Chart showing ABBVIE IRELAND UNLIMITED COs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Elmore Steven 28
#2 Gao Yi 27
#3 Motter Christopher E 23
#4 Degoey David A 23
#5 Betebenner David A 23
#6 Liu Dachun 23
#7 Sarris Kathy 23
#8 Kati Warren M 23
#9 Pratt John K 22
#10 Song Xiaohong 22

Latest patents

Publication Filing date Title
AU2016238925A1 Anti-viral compounds
AU2015201698A1 Process for preparing antiviral compounds
AU2015100283A4 Methods for treating HCV
AU2015201117A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
AU2015201020A1 Methods for treating HCV
AU2015200715A1 Methods for treating HCV
AU2014280934A1 Phosphine ligands for catalytic reactions
AU2014200725A1 Solid compositions
AU2013201585A1 Methods for treating HCV
AU2013201758A1 Methods for treating HCV
AU2012203474A1 Anti-Viral Compounds
AU2012201327A1 Macrocyclic hepatitis C serine protease inhibitors
MX2013009763A Anti-viral compounds.
AU2012200399A1 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors
TW201412707A Anti-viral compounds
AU2011278926A1 Phosphine ligands for catalytic reactions
KR20170037683A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases